摘要
目的 观察及评价托吡酯对各型癫痫的临床疗效及安全性。方法 对 1998年 12月至2 0 0 0年 12月在我院确诊的 14 2例癫痫患者中的 93例采用托吡酯添加治疗、4 9例单药治疗 ,经 8周加量期和 12周稳定期观察后进行评价。结果 添加治疗组及单药治疗组总有效率分别为 79%和84 % ,完全控制率分别为 2 8%和 4 1%。成人有效剂量为 10 0～ 2 0 0mg/d ,儿童 3～ 5mg·kg-1·d-1。不良反应较轻 ,耐受性良好。结论 托吡酯是一种广谱、有效及安全的新型抗癫痫药 ,可作为一线抗癫痫药添加或单独使用。
Objective To observe and evaluate the clinical efficiency and safety of topiramate for treatment of patients with various types of epilepsy Methods 142 patients suffering from epilepsy were underwent the treatment of topiramate, of them 93 cases received a to piramate add on therapy and 49 cases a monotherapy The efficiency and side effects were evaluated after 8 weeks titration period and 12 weeks stabilization period Results The total effective rate was 79% and 84% in add on group and monotherapy group respectively The seizure free rate was 28% and 41% in two groups respectively The optimal dosages were 100～200 mg/d in adults and 3～5 mg/d in children Side effects were generally mild Conclusion Topiramate is a highly effective, safe and widespread first line antiepileptic drug which can be used as a monotherapy or add on treatment
出处
《中华神经科杂志》
CAS
CSCD
北大核心
2002年第2期79-82,共4页
Chinese Journal of Neurology
